Market Cap | ₹1,339Cr |
ROE | 8.47% |
P/E Ratio(TTM) | 30.31 |
EPS(TTM) | 13.99 |
P/B Ratio | 2.99 |
Dividend Yield | 0.24% |
Industry P/E | 41.14 |
Book Value | 142.04 |
Debt to Equity | 0.48 |
Face Value | 5 |
Parent Organisation | Bajaj Healthcare |
Managing Director | Mr. Anil Jain |
NSE Symbol | BAJAJHCARE |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 104.06 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.19 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.19 | ||
Wockhardt | NA (0.00%) | -198.91 |